Monday, October 12, 2026

Goldman Sachs exits consumer banking after $3B+ unit sales to refocus on institutional wealth

Goldman Sachs has divested its entire consumer banking division through a series of sales totaling over $3 billion, including its Marcus loan portfolio (2023), GreenSky platform (2024), and Personal Financial Management unit to Creative Planning (2023). JPMorgan will acquire the Apple Card program in 2026, completing Goldman's retreat from retail finance. The bank is redirecting capital to institutional wealth management, forming Capital Solutions Group in 2025 and acquiring Industry Ventures an

Goldman Sachs exits consumer banking after $3B+ unit sales to refocus on institutional wealth
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Goldman Sachs has sold its Marcus loan portfolio, GreenSky consumer lending platform, and Personal Financial Management unit in a strategic exit from consumer banking that began in 2023. The sales, valued at over $3 billion combined, mark a complete reversal of the bank's retail ambitions launched in 2016.

JPMorgan will take over the Apple Card credit card program from Goldman in 2026, ending the partnership that began in 2019. Goldman's consumer division reportedly lost $3.8 billion between 2020 and 2022, with customer acquisition costs exceeding industry benchmarks.

The bank formed Capital Solutions Group in 2025 to consolidate institutional wealth management operations. Goldman announced acquisitions of Industry Ventures and Innovator Capital Management the same year, deploying capital previously allocated to consumer products into alternative investments and fund management.

Consumer loan servicing costs average $13,000 per origination at government-backed lenders Fannie Mae and Freddie Mac. Specialized fintech firms have reduced these costs through automation, creating structural disadvantages for universal banks without comparable scale in retail operations.

Creative Planning, which acquired Goldman's Personal Financial Management unit in 2023, manages $300 billion in client assets through technology-driven wealth management platforms. The firm's cost-to-income ratio runs 15-20 percentage points below traditional private banks by automating portfolio rebalancing and tax-loss harvesting.

Goldman's institutional business generated return on equity above 15% in 2024, compared to mid-single-digit returns in consumer banking. The bank's investment banking division advised on $1.2 trillion in M&A transactions in 2024, maintaining top-three global rankings.

The consumer banking retreat affects approximately 3,000 employees across lending, deposits, and wealth management units. Goldman reassigned 40% to institutional divisions, while buyers absorbed remaining staff through acquisition agreements.

Industry analysts project specialized financial service providers will capture 60% of new retail banking customers by 2028, up from 35% in 2023. Universal banks face pressure to achieve comparable automation efficiencies or exit segments where scale advantages have eroded.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com